Go Deep
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 21,672 | 77.8 | 2.21 | 0.40 | 99.53 |
| Sep 2026 | 21,672 | 77.8 | 2.21 | 0.40 | 99.53 |
| Sep 2026 | 21,672 | 77.8 | 2.21 | 0.40 | 99.53 |
| Oct 2026 | 21,310 | 80.5 | 2.30 | 0.40 | 103.85 |
| Oct 2026 | 21,201 | 70.8 | 2.21 | 0.40 | 104.08 |
Aarey Drugs & Pharmaceuticals Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 446,255,000.0 | 1,894,724,000.0 | 964,263,000.0 | 841,620,000.0 |
| Net Profit | 10,237,000.0 | 15,574,000.0 | 5,695,000.0 | 10,238,000.0 |
| EPS | 0.4 | 0.6 | 0.2 | 0.4 |
Aarey Drugs & Pharmaceuticals Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 4,711,968,000.0 | 4,724,350,000.0 | 3,951,029,000.0 | 4,128,498,000.0 |
| Net Profit | 39,676,000.0 | 40,239,000.0 | 46,837,000.0 | 37,711,000.0 |
| EPS | 1.4 | 1.4 | 1.8 | 1.5 |
Aarey Drugs & Pharmaceuticals Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 2,972,467,000.0 | 2,905,920,000.0 | 3,032,941,000.0 | 2,913,245,000.0 | — |
| Total Liabilities | 1,468,235,000.0 | 1,521,115,000.0 | 1,705,385,000.0 | 1,739,161,000.0 | — |
| Total Equity | 1,504,232,000.0 | 1,384,805,000.0 | 1,327,556,000.0 | 1,174,084,000.0 | — |
Owes vs Owns
Aarey Drugs & Pharmaceuticals Limited owed ₹0.49 for every ₹1 it owned in Mar 2026, down from ₹0.60 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.49× | 0.52× | 0.56× | 0.60× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Aarey Drugs & Pharmaceuticals Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 1.1%Receivables 43.6%Inventory 14.0%Fixed assets (tangible) 8.6%Long-term investments 1.0%Other assets 31.7%
How it's funded — Mar 2026
Short-term debt 16.5%Payables 27.4%Other liabilities 5.1%Shareholders' equity 50.6%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3.4 | 3.2 | 2.9 | 1.1 |
| Receivables | 129.7 | 133.5 | 184.5 | 189.8 |
| Inventory | 41.5 | 45.5 | 34.7 | 28.8 |
| Fixed assets (tangible) | 25.6 | 15.6 | 13.0 | 13.9 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 3.0 | 2.1 | 1.4 | 0.4 |
| Other assets | 94.1 | 90.7 | 66.9 | 57.3 |
| Liabilities & equity | ||||
| Short-term debt | 49.0 | 32.9 | 28.1 | 33.4 |
| Long-term debt | 1.0 | 2.0 | 3.2 | 4.4 |
| Payables | 81.6 | 102.5 | 128.9 | 127.3 |
| Other liabilities | 15.3 | 14.7 | 10.2 | 8.9 |
| Shareholders' equity | 150.4 | 138.5 | 132.8 | 117.4 |
| Net tangible assets | 150.4 | 138.5 | 132.8 | 117.4 |
Aarey Drugs & Pharmaceuticals Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 101,392,000.0 | 103,004,000.0 | -29,938,000.0 | -12,811,000.0 | — |
| Investing Activities | -124,108,000.0 | -59,394,000.0 | -17,023,000.0 | 4,410,000.0 | — |
| Financing Activities | 21,969,000.0 | -44,821,000.0 | 55,848,000.0 | 13,540,000.0 | — |